Medical Use
Oncaspar (Pegaspargase) is an enzyme that targets asparagine, used as part of a multi-agent chemotherapy regimen for treating patients with:
- -Newly diagnosed acute lymphoblastic leukemia.
- -Acute lymphoblastic leukemia in patients who are hypersensitive to asparaginase.
Warning & Precautions
Monitor patients for 60 minutes after administering Oncaspar 3750 in a setting equipped with resuscitation tools and medications for treating anaphylaxis, such as oxygen, epinephrine, intravenous steroids, and antihistamines.
Severe thrombotic events, including sagittal sinus thrombosis, can occur in patients receiving pegaspargase injections. Discontinue use in patients who experience serious thrombotic events.
Pancreatitis may develop in patients receiving Oncaspar. Evaluate patients with abdominal pain for signs of pancreatitis and discontinue Oncaspar if pancreatitis is confirmed.
Glucose intolerance may occur in patients undergoing Oncaspar therapy, and in some cases, it may be irreversible.
Monitor coagulation parameters at baseline and periodically during and after treatment in patients receiving pegaspargase.
Documentation Availability
Documents required to import ONCASPAR to India?
ONCASPAR can be imported by patients or treating physicians on behalf of patients. The following documentation is required to import the product:
- (i)2 ID proofs along with PAN card details along with attested scanned copies
- (ii)Valid doctor prescription scanned copy
- (iii)Doctor’s MCI number
- (iv)Doctor’s mobile number
- (v)Patients diagnostic reports
How is the order confirmed?
The order will be confirmed only after the receipt of:
- (i)The above-mentioned documents and drug availability.
- (ii)Import permit if applicable.
Sourcing & Delivery
The Rx4U team has extensive experience in sourcing ONCASPAR (Cancer Treatment Medicines) around the world, ensuring global access to the best available treatments for our customers. We are dedicated to promptly dispensing any valid prescription. All prescriptions are verified and dispatched directly to the patient’s address. Our patients are our top priority, and we strive to improve their lives through our services.
FAQ
What is the generic name for the trade name drug Oncaspar®?
The generic name for Oncaspar® is pegaspargase.
Who manufactures Oncaspar®?
Oncaspar® is manufactured by BAXALTA US, Inc.
Is Oncaspar® approved by the FDA?
Yes, Oncaspar® was approved by the FDA in February 1994.
What dosage and form is Oncaspar® available in?
Oncaspar® is available as a 3,750 International Units/5 mL solution in a single-use vial.
What are the most commonly reported side effects of pegaspargase?
The most commonly reported side effects of pegaspargase include central nervous system (CNS) thrombosis, coagulopathy, elevated transaminases, hyperbilirubinemia, allergic reactions (including anaphylaxis), pancreatitis, and hyperglycemia.
What are the storage conditions for Oncaspar®?
Oncaspar® should be stored in a refrigerator at 2°C to 8°C (36°F to 46°F). Do not shake or freeze it, and protect it from light. Do not use it after the expiration date on the vial.
How to order Oncaspar® online in India?
Oncaspar® can be ordered online in India through https://rx4u.in/.
*Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners and Rx4U does not lay any claim on them we only provide Information.
